Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Vaccine|January 31, 2002
The development of a bicistronic plasmid DNA vaccine for B-cell lymphomaGita Singh, Suezanne Parker, Peter HobartRegulatory Toxicology and Pharmacology : RTP|January 24, 2020
Genotoxicity and carcinogenicity risk assessment of prucalopride, a selective 5-hydroxytryptamine 4 receptor agonistHong Wang, Kate Lane, Zhen Lou, et al.Toxicologic Pathology|June 18, 2014
Microscopic background changes in brains of cynomolgus monkeysMark Timothy Butt, Katharine Mason Whitney, Wendell Davis, et al.Journal of Immunotoxicology|July 11, 2009
Immunotoxicity profile of natalizumabNancy G Wehner, Carolyn Gasper, George Shopp, et al.International Journal of Toxicology|June 9, 2016
Workshop Proceedings: Streamlined Development of Safety Assessment Programs Supporting Orphan/Rare Diseases-Are We There Yet?Krishna P Allamneni, Suezanne Parker, Charles A O'Neill, et al.The Journal of Pharmacology and Experimental Therapeutics|June 22, 2011
In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1aXiao Hu, Kenneth Olivier, Evelyne Polack, et al.Toxicologic Pathology|May 18, 2010
Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendationsJohn L Vahle, Gregory L Finch, Shawn M Heidel, et al.Regulatory Toxicology and Pharmacology : RTP|July 21, 2018
Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challengesFrank R Brennan, Laura Andrews, Antonio R Arulanandam, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2024
Lipid nanoparticle delivery of TALEN mRNA targeting LPA causes gene disruption and plasma lipoprotein(a) reduction in transgenic miceDaniel A Garcia, Abigail F Pierre, Linda Quirino, et al.Human Gene Therapy|September 14, 2002
Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routesJudith E Epstein, Edward J Gorak, Yupin Charoenvit, et al.Pageof 2